Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
UBC Medical Indonesia Tbk. operates as a leading provider of medical equipment and services in Indonesia, focusing on advanced diagnostic and therapeutic solutions. The company differentiates itself through its extensive distribution network across the archipelago and partnerships with global medical technology firms, enabling it to capture a significant market share in a rapidly growing healthcare sector.
UBC Medical generates revenue primarily through the sale of medical devices and equipment, complemented by service contracts and consumables. The company benefits from strong pricing power due to its established brand reputation and exclusive distribution agreements with leading international manufacturers, allowing it to maintain healthy gross margins.
Regulatory changes impacting medical device approvals
Trends in healthcare spending in Indonesia
Partnership announcements with global medical technology firms
New product launches in the medical equipment sector
Technological disruption from emerging medical technologies
Regulatory changes affecting product approvals and market access
Increased competition from local and international medical equipment suppliers
Price competition leading to margin compression
Low liquidity risk due to a current ratio of 2.75
Potential risks associated with inventory management and obsolescence
high - the healthcare sector is closely tied to GDP growth and consumer spending, as increased economic activity typically leads to higher healthcare expenditures.
Moderate - rising interest rates can increase financing costs for capital expenditures, potentially impacting expansion plans and profitability, although the low debt/equity ratio mitigates this risk.
minimal - the company has a low debt/equity ratio of 0.18, indicating limited reliance on external financing.
growth - the company's strong revenue growth and expanding market presence appeal to growth-oriented investors.
moderate - historical volatility is expected to be moderate given the company's stable revenue streams and market position.
